SCHEMBL21691644

SCHEMBL21691644

N#Cc1ccc(-c2cc(-c3ccc4c(c3)sc3ccccc34)c(C#N)cc2-c2ccc3c(c2)sc2ccccc23)c(C#N)c1

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ STS P08842 1/20 0.36
▸ GPR3 P46089 1/20 0.35
▸ LIMK1 P53667 1/20 0.34
▸ ALOX5 P09917 1/20 0.33
▸ PRSS12 P56730 1/20 0.32
▸ FLT3 P36888 3/20 0.32
▸ SLC22A12 Q96S37 1/20 0.32
▸ G6PD P11413 1/20 0.32
▸ CA1 P00915 2/20 0.32
▸ CA2 P00918 2/20 0.32
▸ PRMT5 O14744 1/20 0.32
▸ WDR77 Q9BQA1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23625848 0.92 STS (0.42) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL21693259 0.90 TNKS (0.37) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL21692241 0.86 STS (0.40) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL21692702 0.85 ALDH1A1 (0.41) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL21693206 0.85 ALDH1A1 (0.41) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL21693196 0.85 STS (0.39) STSGPR3ALOX5PRSS12FLT3
SCHEMBL21693205 0.83 FLT3 (0.34) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL21691632 0.83 GPR3 (0.38) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL21692345 0.83 PRMT5 (0.39) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL21692701 0.82 ALDH1A1 (0.39) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11053228-B2 Condensed cyclic compound, composition including the condensed cyclic compound, and organic light-emitting device including the condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-07-06 — — US disclosed
US-20200031812-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND SAMSUNG SDI CO., LTD. (KR) 2020-01-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11053228-B2 Condensed cyclic compound, composition including the condensed cyclic compound, and organic light-emitting device including the condensed cyclic compound CCNL2, ARL1, CRY1 ALDH1A1 738/4885MAPT 1412/4885HPGD 3809/4885
US-20200031812-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND CCNL2, ARL1, CRY1 ALDH1A1 738/4885MAPT 1412/4885HPGD 3809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback